Method for establishing anti-hepatitis C virus drug screening experimental animal model
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 李卫云
- Publication Date
- 2006-12-20
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of hepatitis C virus. Specifically, the invention relates to a method for establishing anti-hepatitis C virus drug screening and an experimental animal model. Background technique
[0002] About 170 million people worldwide are infected with hepatitis C virus (HCV) (Alter M, 1997). The infection rate in developed countries is nearly 2%, and the HCV natural infection rate in my country is about 2-3%, which belongs to the high infection area of HCV (Wen Yumei, 1999). 70-80 of acute hepatitis C patients will develop into chronic hepatitis, and 5-10 of them will develop into liver cirrhosis and liver cancer (Jin Qi, 2001). Since Choo et al. successfully cloned and isolated HCV in 1989, the molecular biology research of HCV has made great progress. So far known HCV has 6 genotypes and more than 30 subtypes. However, because the cell receptor of HCV has not been fully determined, lack of efficient cell culture...